Furthermore, immunohistochemistry (IHC) analysis demonstrated that the ratio of CD4+ T cells was reduced in TMZ-treated tumor sections, whereas the ISP-I-treated group exhibited an opposite effect (Fig. 4H). Here, CD4 is linked to neoplasm.